Lowering of dopamine metabolites in rat brain by harmaline
- 1 September 1981
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 33 (1) , 255-256
- https://doi.org/10.1111/j.2042-7158.1981.tb13773.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- An explanation for deamination of phenylethylamine by multiple types of monoamine oxidasePharmacological Research Communications, 1979
- THE EFFECTS OF CHRONIC REGIMENS OF CLORGYLINE AND PARGYLINE ON MONOAMINE METABOLISM IN THE RAT BRAINJournal of Neurochemistry, 1979
- Selective in Vivo Inhibition of Monoamine Oxidase in Rat Tissues by N-[2-(o-Chlorophenoxy)-Ethyl]-CyclopropylamineExperimental Biology and Medicine, 1978
- Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated ratsLife Sciences, 1978
- Monoamine oxidase A and B: A useful concept?Biochemical Pharmacology, 1978
- The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formationEuropean Journal of Pharmacology, 1975
- Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugsLife Sciences, 1974
- Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N[2(ochlorophenoxy)-ethyl]-cyclopropylamineBiochemical Pharmacology, 1968
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968
- REVERSIBLE INHIBITION OF BRAIN MONOAMINE OXIDASE IN VITRO AND IN VIVOActa Neurologica Scandinavica, 1962